🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12361+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12361 recruiting trials

NARecruitingNCT05960461

Families Moving Forward (FMF) Connect Pro for Mental Health Providers

🏥 University of Rochester📍 1 site📅 Started Mar 2024View details ↗
Phase 1, PHASE2RecruitingNCT06316427

Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Malignancies

🏥 Beijing GoBroad Hospital📍 4 sites📅 Started Mar 2024View details ↗
Phase 1RecruitingNCT06218914

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

🏥 AstraZeneca📍 18 sites📅 Started Mar 2024View details ↗
NARecruitingNCT05808153

Innovative Imaging and Cognitive BIOmarkers to Predict Huntington's Disease Progression

🏥 Assistance Publique - Hôpitaux de Paris📍 1 site📅 Started Mar 2024View details ↗
Phase 1RecruitingNCT06418113

Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma

🏥 Hospital San Carlos, Madrid📍 1 site📅 Started Mar 2024View details ↗
Phase 2RecruitingNCT06323460

Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer

👨‍⚕️ Sujith Baliga, Ohio State University Comprehensive Cancer Center📍 1 site📅 Started Mar 2024View details ↗
RecruitingNCT05954455

Exploring Bulbar Function, Speech And Communication Development in SMA Type 1

🏥 Institute of Child Health📍 1 site📅 Started Mar 2024View details ↗
Phase 1, PHASE2RecruitingNCT05692024

COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER

👨‍⚕️ Aparna R Parikh, MD, MS, Massachusetts General Hospital📍 1 site📅 Started Mar 2024View details ↗
NARecruitingNCT06198517

Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCT

🏥 Yi Zhang📍 4 sites📅 Started Mar 2024View details ↗
Phase 1RecruitingNCT06752746

A Study of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 9MW3011 in Patients With Polycythemia Vera

🏥 Mabwell (Shanghai) Bioscience Co., Ltd.📍 6 sites📅 Started Mar 2024View details ↗
Phase 2RecruitingNCT06205121

Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

👨‍⚕️ Piotr Iwanowski, MD, CMO📍 28 sites📅 Started Mar 2024View details ↗
NARecruitingNCT06270667

Effects of Exercise Training in Survivors of Lymphoma

👨‍⚕️ Tormod S. Nilsen, PhD, Norwegian School of Sport Sciences📍 2 sites📅 Started Mar 2024View details ↗
NARecruitingNCT06805669

This is a Randomized Study of Early Involvement of Palliative Care Along Side Standard Treatment Versus Standard Treatment Alone in Newly Diagnosed Patients With Advanced or Metastatic Soft Tissue Sarcoma (SARQUALITY)

👨‍⚕️ Albiruni R. Abdul Razak, MOUNT SINAI HOSPITAL📍 1 site📅 Started Mar 2024View details ↗
Phase 1, PHASE2RecruitingNCT06375733

A Study of GFH009 in Combination With Zanubrutinib in Subjects With Relapsed or Refractory DLBCL

👨‍⚕️ Keshu Zhou, MD, Affiliated Cancer Hospital of Zhengzhou University Henan Cancer Hospital📍 2 sites📅 Started Mar 2024View details ↗
RecruitingNCT06397794

Navigating Pregnancy and Parenthood With Lyme Disease

👨‍⚕️ Sarah B. Mulkey, MD, PhD, Children's National Research Institute📍 1 site📅 Started Mar 2024View details ↗
Phase 1RecruitingNCT06249438

A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy

👨‍⚕️ Nan Shen, MD & PhD, Department of Rheumatology, RenJi Hospital, School of Medicine, Shanghai JiaoTong University📍 1 site📅 Started Mar 2024View details ↗
Phase 2RecruitingNCT05987124

Defibrotide Dose-escalation for SOS Post-HSCT

👨‍⚕️ Mitchell Cairo, MD, New York Medical College📍 1 site📅 Started Mar 2024View details ↗
Phase 1RecruitingNCT06259552

A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors

👨‍⚕️ Guidong Zhu, SparX Biotech📍 4 sites📅 Started Mar 2024View details ↗
Phase 2RecruitingNCT06301399

Rituximab Combined With Prior Therapy in Advanced Hepatocellular Carcinoma: Efficacy & Safety Study

🏥 Tianjin Medical University Cancer Institute and Hospital📍 1 site📅 Started Mar 2024View details ↗
RecruitingNCT06124196

Wearable Technology to Evaluate Hyperglycemia and HRV in DMD

👨‍⚕️ Jaclyn Tamaroff, MD, Vanderbilt University Medical Center📍 1 site📅 Started Mar 2024View details ↗
← PreviousPage 315 of 619Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →